Rivaroxaban for non-valvular atrial fibrillation and venous thromboembolism in the Netherlands: a real-world data based cost-effectiveness analysis
| Verfasser: | |
|---|---|
| Dokumenttyp: | Artikel |
| Erscheinungsdatum: | 2019 |
| Reihe/Periodikum: | Journal of Medical Economics ; volume 22, issue 4, page 306-318 ; ISSN 1369-6998 1941-837X |
| Verlag/Hrsg.: |
Informa UK Limited
|
| Sprache: | Englisch |
| Permalink: | https://search.fid-benelux.de/Record/base-29601874 |
| Datenquelle: | BASE; Originalkatalog |
| Powered By: | BASE |
| Link(s) : | http://dx.doi.org/10.1080/13696998.2018.1563404 |
